ID   TSRI51i-HDF509
AC   CVCL_UF50
SY   HDF51i-509; HDF51i509; HDF51iPS509
DR   Wikidata; Q98133644
RX   PubMed=23514962;
RX   PubMed=26892726;
CC   Omics: Genome sequenced.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF42 ! HDF-f
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=23514962; DOI=10.1038/jid.2013.139; PMCID=PMC3714355;
RA   Jones J.C., Sabatini K., Liao X.-Y., Tran H.T., Lynch C.L., Morey R.E.,
RA   Glenn-Pratola V.L., Boscolo F.S., Yang Q.-H., Parast M.M., Liu Y.,
RA   Peterson S.E., Laurent L.C., Loring J.F., Wang Y.-C.;
RT   "Melanocytes derived from transgene-free human induced pluripotent
RT   stem cells.";
RL   J. Invest. Dermatol. 133:2104-2108(2013).
//
RX   PubMed=26892726; DOI=10.1038/ncomms10536; PMCID=PMC4762882;
RA   Bhutani K., Nazor K.L., Williams R., Tran H., Dai H., Dzakula Z.,
RA   Cho E.H., Pang A.W.C., Rao M.S., Cao H., Schork N.J., Loring J.F.;
RT   "Whole-genome mutational burden analysis of three pluripotency
RT   induction methods.";
RL   Nat. Commun. 7:10536.1-10536.8(2016).
//